Camposol has opened a new biofactory in Peru as part of its horticultural expansion strategy across Chile, Colombia, Uruguay, and Mexico. The facility is located at the company's operations in Chao, Virú (Trujillo), and covers 2,000 square meters, with an annual production capacity of up to 5 million blueberry plants. It combines in vitro and ex vitro processes in a single site using biotechnology systems designed for plant propagation.
Ricardo Naranjo, CEO of Camposol, said, "The opening of this biofactory reinforces our commitment to innovation and sustainability." He noted that the facility will support the development and multiplication of proprietary blueberry genetics aligned with market demand. "With this new biofactory, we will be able to scale up the planting plan to new hectares using our own blueberry genetics, as well as replant existing areas with more competitive varieties," he said. Naranjo added that the biofactory will help ensure plant availability for the company's long-term expansion plans.
Camposol recently received an upgraded credit rating from Fitch Ratings, raised to B+ with a stable outlook. Naranjo said, "This progress is the result of the efforts of thousands of people who, with integrity, collaboration and passion, work the land to improve lives, making it possible for our vision of sustainability and excellence to translate into concrete results." He said the company intends to continue pursuing long-term growth across the regions in which it operates.
In Chile, Camposol has started its cherry harvest season as part of efforts to broaden its global portfolio. The company currently manages 150 hectares of cherry orchards in full production, primarily cultivating Lapins and Santina varieties. These cultivars are recognised in export markets for size, color, and flavor. "Our plantations include high-tech greenhouses, which allow us to ensure the quality and consistency of the fruit from the field to the final consumer," Naranjo told Agraria.
Source: Blueberries Consulting
